Dr Mark Devlin

Biography

After obtaining a PhD in Pharmacology from the University of Melbourne, Mark has worked in a variety of roles focused on academic-based drug discovery and development in a number of therapeutic areas including, pain, inflammation, autoimmune disease and oncology. Mark joined Peter Mac in 2008 to head the CRC for Cancer Therapeutics (CTx) Translational Research Laboratory where Peter Mac scientists, working as part of a larger multi-disciplinary team, are involved in the development and validation of small molecule therapeutics for a variety of cancers.

Research Interest

  Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management